| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. (RNA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. RNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 283.4K | $3.67M | - | |
| Other | 205.0K | $2.65M | - | |
| Other | 116.9K | $1.51M | - | |
| Other | 91.6K | $1.19M | - | |
| Other | 79.0K | $1.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Flanagan W. Michael | Csto | Sale+OE | 62,500 | $47.62 | $2,976,112.50 | -42.3% | |
| Sep 23, 2024 | Flanagan W. Michael | Csto | Sell | 25,000 | $43.95 | $1,098,732.89 | -13.7% | |
| Sep 23, 2024 | Boyce Sarah | President And CEO | Sell | 32,880 | $44.00 | $1,446,723.29 | -12.3% | |
| Sep 23, 2024 | MacLean Michael F | Chief Financial Officer | Sell | 11,510 | $44.00 | $506,440.00 | -10.7% | |
| Sep 23, 2024 | McCarthy Teresa | Chief Human Resources Officer | Sell | 13,153 | $44.00 | $578,737.26 | -16.0% | |
| Sep 19, 2024 | Levin Arthur A | Director | Sale+OE | 5,000 | $45.73 | $228,658.00 | -25.2% | |
| Sep 11, 2024 | Flanagan W. Michael | Csto | Sale+OE | 111,394 | $40.40 | $4,500,244.20 | -34.4% | |
| Sep 11, 2024 | McCarthy Teresa | Chief Human Resources Officer | Sale+OE | 25,000 | $40.40 | $1,010,042.50 | -30.4% | |
| Aug 19, 2024 | Levin Arthur A | Director | Sale+OE | 5,000 | $45.19 | $225,946.50 | -25.2% | |
| Aug 6, 2024 | Boyce Sarah | President And CEO | Sale+OE | 28,000 | $43.35 | $1,213,822.40 | -12.0% |